Home › Heart Failure › NCT06291922

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. ≥ 18 years of age
2. Newly implanted with a HeartMate 3™ LVAD for the first time
3. Able to ambulate independently (with or without the use of an assistive device)
4. Owns a smartphone with Internet connection
5. Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge

Exclusion Criteria:

1\. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)

About the study

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.

What is being tested

• Exercise Intervention (behavioral)
• Usual Care (behavioral)

Sponsor: University of Pennsylvania · Participants: 100 · Started: Aug 14, 2024

Contact the study team

• Clinical Research Coordinator · Phone: 215-615-4480

Official record on ClinicalTrials.gov — NCT06291922

Locations in the U.S.

Conditions

• Heart Failure

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.